Walgreens Boots Alliance Inc
What Stores Are Closed on Thanksgiving in 2021?
Walgreens CEO Roz Brewer Is a Powerhouse, VP Harris' Sorority Sister
Walgreens Stock Looks Like a Buy Before Its Q2 Earnings
AmerisourceBergen and Walgreens Sign 'Deal of a Lifetime'
How Walgreens Makes Money Amid the COVID-19 Pandemic
Walgreens Stock Looks Like a Buy for Long-Term Investors
Must-know update: Redbook Index same-store sales data released
The Redbook Index released the same-store weekly data on Tuesday, March 11, 2014.
Could the Rite Aid–Walgreens Merger Get Competitive?
In the Rite Aid–Walgreens merger, Walgreens is paying about 0.6x trailing-12-month revenues and 13.6x trailing-12-month EBITDA.
Glenview Capital opens new position in Danaher
Glenview Capital Management added a new position in Danaher Corp. (DHR) in the third quarter. The position accounted for 1.99% of the fund’s total portfolio.
Blue Ridge Capital exits stake in Citigroup
Citigroup posted a $3.4 billion net income, up by 8% with revenues of $19.6 billion, and the net interest margin increased to 2.91% for 3Q14.
Blue Ridge Capital increases holding in SiriusXM
The third quarter of 2014 was by far the best for SiriusXM in terms of market penetration as well as increasing revenues.
Investment-Grade Corporate Bonds’ Issuance Fell Last Week
Investment-grade corporate bonds worth $28.8 billion were issued in the primary market in the week to May 27, 2016.
Walgreens’s Deal with Rite Aid Still on, but Delayed
In October 2015, Walgreens Boots Alliance (WBA) announced its intention to acquire Rite Aid (RAD) for a total enterprise value of $17.2 billion.
Rite Aid’s Revenue Rose and Income Fell in Fiscal 3Q16
Rite Aid (RAD) has a market cap of $8.2 billion. After the fiscal 3Q16 earnings report, Rite Aid fell by 0.25% to close at $7.88 per share as of December 17, 2015.
Can the Walgreens-Rite Aid Merger Get Antitrust Approval?
The Walgreens-Rite Aid merger is a combination of the first and third largest pharmacies in the United States.
The WBA-RAD Merger and the 43% Fall in Rite Aid Stock
Uncertainty over closing the proposed merger between Walgreens Boots Alliance (WBA) and Rite Aid (RAD) has resulted in a 42.8% fall in RAD stock YTD.
Here’s Why Walgreens Stock Crashed despite Strong Q3 Results
After Walgreens announced its fiscal Q3 results, Amazon announced its plan to acquire PillPack, an online pharmacy company, and WBA stock crashed.
CVS versus Walgreens: Which Has a More Diversified Business Model?
CVS generates close to 70% of its annual sales by offering a full range of pharmacy benefit management services.
Glenview Capital increases stake in Fidelity National Financial
Glenview Capital Management added to its position in Fidelity National Financial (FNF) in the third quarter. Currently, the position accounts for 1.70% of the fund’s total portfolio.
Kroger versus Walmart: Which Grocery Stock Is Best?
Despite some impressive signs of Kroger’s (K) success, Walmart stock (WMT) is the better pick for the grocery sector. Here’s why.
Costco’s Industry Positioning: A Porter’s 5 Force Analysis
Costco’s suppliers include companies like PepsiCo (PEP), Procter & Gamble (PG), and the Kraft Heinz Company (KHC). No single supplier accounts for over 5% of revenue.
Glenview Capital raises position in Endo International
Glenview Capital Management added to its position in Endo International Plc (ENDP) in the third quarter. Currently, the position accounts for 2.02% of the fund’s total portfolio.
NYSTRS reduced its position in Apache Corporation
The NYSTRS decreased its position in Apache Corporation from 0.20% in 3Q14 to 0.12% in 4Q14—according to the latest SEC 13F filings.
Walgreens Boots Alliance Issued the Most High-Grade Bonds
Walgreens Boots Alliance (WBA) issued Baa2/BBB rated high-grade bonds worth $6.0 billion through five parts on May 26.
Highfields Capital Management’s positions in 3Q14
Highfields Capital Management LP is based in Boston. The fund was founded by Jonathon Jacobson in 1998. The fund’s US long portfolio declined slightly to $12.8 billion in the third quarter.
Walgreens Offers Free COVID-19 Testing, Stock Faces Pressure
What to Expect from Walgreens’ Q2 Earnings
Analysts expect Walgreen’s second-quarter sales to rise 2.1% YoY to $35.3 billion. The company is scheduled to release its earnings results on April 2.
GNC Holdings Reports Mixed 4Q15 Results: Where to This Year?
GNC Holdings (GNC) has a market cap of $2.2 billion. GNC rose by 1.6% to close at $26.98 per share on February 11, 2016.
Why did Viking Global Investors establish a position in Cemex?
Viking Global Investors opened a new position in Cemex SAB de CV.
High-grade bond supply spike triggers hope for record year
Last week was strong in terms of issuance volumes in the primary capital markets. High-quality bond issuance touched $51.3 billion across 42 issues in the week ending November 7.
Will Walgreens’ Q3 Results Beat Wall Street’s Forecast?
Unlike several other US companies, Walgreens didn’t suspend its dividends due to COVID-19. As of July 6, the company’s dividend yield was 4.2%.
Costco Stock Rose after Reporting Strong Sales in June
On Wednesday, Costco (NASDAQ:COST) reported its net sales for June. For the five weeks ended on July 5, the company reported net sales of $16.18 billion.
Walgreens Reports Lower Q3 Earnings, Suspends Buybacks
Walgreens Boots Alliance (NASDAQ:WBA) missed Wall Street’s earnings forecast for the third quarter of fiscal 2020, which ended on May 31.
Walmart to Boost Pharmacy Business with CareZone’s Tech Acquisition
Today, CNBC reported that Walmart (NYSE:WMT) has acquired prescription management technology from CareZone to boost its pharmacy space.
Why Walgreens Stock Fell despite Upbeat Q2 Earnings
Walgreens Boots Alliance (NASDAQ:WBA) reported strong earnings for the second quarter of fiscal 2020. The second quarter ended on February 29.
Bears Return to Walgreens Stock, Challenges Persist
Walgreens Boots Alliance stock is feeling pressure again. The stock fell about 6% on Wednesday, which reflects its weaker start to fiscal 2020.
Can Kroger Gain Momentum in 2020?
Kroger’s performance in recent quarters compared to its peers has left its investors unimpressed. In 2019, Kroger stock rose 5.4%.
Walgreens Posts Disappointing Q1 Earnings Results
Today, Walgreens Boots Alliance reported lower-than-expected results for the first quarter of fiscal 2020. The adjusted EPS fell on a YoY basis.
Alphabet’s Other Bets: Three Things to Know as 2020 Starts
To diversify its business outside the advertising market, Alphabet is building several startup businesses in its Other Bets segment.
Why Walgreens’ Earnings Will Likely Decline in Q1
Walgreens Boots Alliance (WBA) will announce its earnings for the first quarter of fiscal 2020 before the markets open on January 8.
Dow Jones Index’s Top Gains and Losses in 2019
Apple (AAPL) kept the throne with a gain of almost 85% this year. The company is the third biggest component of the Dow Jones Index.
Kroger Stocks Gains on Evercore Rating Upgrade
Today, Evercore ISI upgraded its rating on Kroger to “outperform” from “in line” and Citigroup increased its price target on the stock to $32 from $30.
Can FedEx Have a Good Holiday Season sans Amazon?
Delivery companies are poised to benefit from higher online retail sales this holiday season, but FedEx’s split from Amazon could make things dicey for it.
Can the US Cannabis Market Rescue ACB?
Aurora Cannabis (ACB) stock isn’t in the best shape today. As reported by BNN Bloomberg, the company’s CEO, Terry Booth, is justifiably worried.
CVS Health Stock: What’s Fueling Growth and Will the Uptrend Last?
CVS Health stock is up about 13% in November. Strong financial performance is driving the stock higher, but low earnings growth could limit further upside.
Why Gap Wants to Sell Its Merchandise on Amazon
Gap (GPS) recently announced that it will start selling merchandise on Amazon.
Maverick Capital lowers position in Baidu, Inc.
Maverick Capital lowered its position in Baidu, Inc. in 3Q14. The position accounts for 0.36% of the fund’s total portfolio in the third quarter.
New bond supply spikes on Chinese financials and Walgreens issues
In a rare week, emerging market (EMB) (VWO) borrowers were the most prolific in U.S. investment-grade bond markets.
Will falling credit card debt affect stocks like Walgreens?
Consumer credit figures for February will be released by the U.S. Federal Reserve on Monday, April 7. It’s a monthly release, and the headline number for the report is total consumer debt.
FedEx Stock Gains Due to Strong Cyber Monday Projections
FedEx (FDX) stock gained nearly 3% on November 22. The company expects record package volumes on Cyber Monday.
Walgreens: Reports of KKR Buyout Offer, Stock Rose
Walgreens Boots Alliance (WBA) stock rose 5.1% on Monday. Bloomberg reported that private equity firm KKR has formally offered to buy the company.
CVS Keeps Beating Estimates, Raises Earnings Outlook
CVS Health (CVS) again beat analysts’ revenue and EPS estimates when it released its Q3 earnings today. Its stock was up about 3% in premarket trading.
Why Walgreens Is Mulling Over Going Private
Reuters reports that Walgreens Boots Alliance (WBA) is exploring options to go private and has engaged Evercore Partners to put together a deal.
Why CVS Stock Looks Strong Ahead of Q3 Earnings
CVS Health (CVS) is slated to announce its third-quarter earnings results tomorrow. We believe the company sustained its sales momentum in the quarter.
Why apparel sales may boost April earnings for retailers like Gap
Both the International Council of Shopping Centers (or ICSC) Goldman Sachs Store Sales report and the Johnson Redbook Index report for the week ended April 5 will be released on Tuesday, April 8.
What are the major indicators covered in the Redbook Index?
The Redbook Index tries to provide near-real-time weekly assessments of the consumer buying activity in large retail chain stores.
Walgreens Stock: Q4 Beat Might Not Spur Recovery
Walgreens Boots Alliance (WBA) struggled in fiscal 2019. Sales headwinds and pressure on margins from reimbursements dragged the stock down.
Walgreens Stock: What to Expect from Its Q4 Earnings
Walgreens is scheduled to report its fourth-quarter earnings before the markets open on October 28. We expected a limited downside in Walgreens stock.
Apple Stock Gains 50%, Drives Dow Jones Higher in 2019
Apple (AAPL) shares have gained close to 50% year-to-date. The stock is trading at $235.87, while it’s valued at $1.07 trillion.
How US Retail Sales Changed in Two Decades
The retail sales for 2018 were $4.3 trillion. From January to July 2019, the retail sales in this category rose 3.5% over the comparable period in 2018.
DJIA Ends Day in Green despite Europe’s Grim Data
The Dow Jones Industrial Average Index or DJIA gained a marginal 0.06% today to close trading just below 27,000—despite a bleak picture in Europe’s economy.
Walgreens Stock Fizzles after Brief Recovery
Pressure on Walgreens (WBA) stock had started easing a bit. However, the revival was short lived, and WBA fell about 2% last week.
FedEx Teams Up with Google Wing to Test Drone Delivery
FedEx (FDX) has teamed up with Alphabet’s (GOOGL) Wing to make drone delivery a reality. Let’s take a closer look at how.
Dow Jones Index Falls after Rising for Eight Days
The Dow Jones Industrial Average Index has fallen 0.4% or by 115 points today. The index is trading lower after rising for eight consecutive trading sessions.
WBA and KHC Stocks Cost Investors despite Recovery
KHC and WBA stocks have cost investors dearly. Warren Buffett’s Berkshire Hathaway has suffered for being Kraft Heinz’s biggest shareholder.
The Dow Jones Rises for Eight Consecutive Days
The Dow Jones Industrial Average has risen 51.5 points today—up for the eighth consecutive trading session. The DJIA is up 1,100 points since September 3.
Walgreens Stock: Deutsche Bank Recommends a ‘Sell’
Deutsche Bank started coverage on Walgreens stock with a “sell” recommendation. The stock closed 4.3% lower on Thursday after the news.
Why Walgreens Stock Underperformed CVS in August
Walgreens Boots Alliance (WBA) stock underperformed CVS Health (CVS) stock last month, with Walgreens falling 6% and CVS rising about 9%.
Walgreens: Pain Eases, but It’s a Far Cry from Recovery
Walgreens stock is underperforming and is trading at a low valuation. Despite this low valuation, the stock’s recovery could take time.
Walgreens or CVS Stock: Which Is a Better Value Buy?
Walgreens and CVS Health shares are trading at a low valuation multiple. The stocks have fallen 22.3% and 8.7%, respectively, in 2019.
Why These Dividend-Paying Consumer Stocks Look Attractive
As the broader markets take a hit, dividend-paying consumer stocks seem like a safe bet due to the sector’s defensive nature.
Walgreens Will Close 200 US Stores
In a regulatory filing on Tuesday, Walgreens Boots Alliance (WBA) announced that it will close 200 stores in the US to focus on store optimization.
Walgreens Boots Alliance Stock: Is Recovery a Long Shot?
Walgreens Boots Alliance (WBA) stock is down about 17% since the company announced weak second-quarter earnings on April 2.
Will Pressure on Earnings Limit the Upside in CVS Health Stock?
CVS Health (CVS) impressed investors with its first-quarter sales and earnings.
What to Expect from CVS Health’s First-Quarter Results
CVS Health (CVS) plans to announce its first-quarter results on Wednesday, May 1.
Pharmaceutical Retailers Underperformed Broader Markets
CVS and Walgreens stock fell 17.7% and 7.4%, respectively, in the first quarter, which reflected the weak earnings outlook.
Consumer Staples Stocks: Stragglers in Q1
Despite 10.5% growth in the first quarter, the Consumer Staples Select Sector SPDR ETF (XLP) lagged the benchmark index, which rose 13.1%.
Amazon Challenges Walgreens and CVS Health Again
Amazon (AMZN) recently began letting customers use funds in their special healthcare savings account to pay for purchases of eligible products on its marketplace, the company confirmed to CNBC.
Walgreens Stock Continues to Fall Due to Multiple Price Cuts
Walgreens Boot Alliance (WBA) shares have taken a beating the past few days. Multiple analysts lowered their target price on the stock.
What’s Hurting CVS and Walgreens Stocks?
Walgreens Boots Alliance stock (WBA) fell 6.4% on March 1 after Baird’s reduction in target price.
How Is Walgreens Boots Alliance Positioned in 2019?
As of January 18, Walgreens Boots Alliance (WBA) stock has risen 6.0% since the start of 2019.
Five Consumer Staples Stocks to Be Thankful For—Even This Year
So far, 2018 has been a difficult year for the consumer staples industry—even tougher than last year.
CVS: Analysts’ Ratings and Target Prices
CVS Health posted stronger-than-expected third-quarter results on November 6. A few analysts raised the target prices on CVS stock.
Walgreens: Key Revenue Drivers in Fourth Quarter of Fiscal 2018
Walgreens’s Retail Pharmacy USA division accounted for 76% of fourth-quarter sales and increased 14.4% YoY to $25.5 billion.
Strong Q2 2018 Results Cushion CVS Health’s Falling Share Price
CVS Health’s (CVS) better-than-expected second-quarter results managed to please investors.
How Pharmacies and Drugstores Are Defending against Amazon
Amazon’s (AMZN) purchase of PillPack is expected to pose a threat to existing players in the pharmaceutical space.
CVS Health and Walgreens: Financial Health
CVS recorded total sales of $186 billion (+4% YoY) in the last 12 months. The Pharmacy Services segment was the company’s biggest moneymaker.
CVS Health versus Walgreens: Comparing Pharmacy Giants
Around 70% of the US population lives within three miles of a CVS store, while more than 75% of the population lives within five miles of a Walgreens store.
Drugstore Stocks Tumble ahead of Trump’s New Drug Policy
The stocks of top drugstore chains CVS Health (CVS) and Walgreens Boots Alliance (WBA) were down yesterday amid ongoing tensions regarding a policy change in US drug pricing.
Consumer Stocks Tumble on Trade War Worries
On April 2, the S&P 500 Index fell ~2.2% as China raised tariffs on 128 US products, including frozen pork, wine, fruit, and nuts.
How the Drug Store Industry Is Changing
The top three drugstore chains in the US are in the process of forming new associations through mergers and acquisitions to create a more diversified portfolio and protect themselves from the growing online threat.
How Walgreens’s International Businesses Performed in 1Q18
In this part of our series, we’ll discuss the performance of Walgreens Boots Alliance’s (WBA) Retail Pharmacy International and Pharmaceutical Wholesale businesses in 1Q18.
Wall Street’s Take on Rite Aid after 3Q17 Results
Wall Street kept its stance unchanged on Rite Aid (RAD) after its third-quarter results. Evercore ISI, however, initiated coverage on the company on January 5 with an “underperform” rating.
Walgreens Delivers Strong Top-Line Growth in 1Q18
As we’ve discussed, Walgreens Boots Alliance (WBA) reported its 1Q18 results on January 4. The company’s top line increased 7.9% YoY (year-over-year) to $30.74 billion.
Walgreens Beats 1Q18 Sales and Earnings Expectations
Walgreens Boots Alliance (WBA) reported its results for 1Q18 on Thursday, January 4. The results relate to the three-month period ending November 30, 2017.
Stock Watch: No Respite for Rite Aid’s Shareholders
As we discussed throughout this series, Rite Aid (RAD) reported better-than-expected quarterly profits on January 3. However, the third quarter results couldn’t stop the slide in the company’s stock price.
Depressed Retail Pharmacy Gross Profit Impacts Rite Aid’s 3Q17
Rite Aid Corporation (RAD) reported third-quarter results on January 3. The company’s adjusted net earnings from continuing operations stood at $1.6 million, or $0.00 per diluted share, compared to $26.8 million or $0.03 per diluted share during the same period last year.
Rite Aid’s Top Line Plunges for the 3rd Straight Quarter in 3Q17
Rite Aid (RAD) reported its 3Q17 results after the market closed on January 3. The company’s top line plunged 5.6% YoY (year-over-year) to $5.35 billion (excluding discontinued operations).
Rite Aid’s 3Q17 Results: A Quick Look
Rite Aid Corporation (RAD) reported results for 3Q17 on Wednesday, January 3. The results relate to the three-month period ending December 2, 2017.
Deal of the Year: CVS to Buy Aetna for $69 Billion
CVS Health (CVS), America’s largest pharmacy chain, announced a $69 billion deal to purchase Aetna (AET), the country’s third-largest insurance company, on December 3, 2017.